Cargando…
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
Autores principales: | White, Andrew A., Cahill, Katherine N., Jerschow, Elina, Kuruvilla, Merin, Sehanobish, Esha, Bensko, Jillian, Laidlaw, Tanya M., Levy, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130496/ https://www.ncbi.nlm.nih.gov/pubmed/33965591 http://dx.doi.org/10.1016/j.jaip.2021.04.060 |
Ejemplares similares
-
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021) -
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Buchheit, Kathleen, et al.
Publicado: (2020) -
The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
por: Kuruvilla, Merin E, et al.
Publicado: (2020) -
Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016) -
Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)